Athena Diagnostics, Inc. v. Mayo Collaborative Servs., LLC
Case Details
- Judge(s)
- Per Curiam
- Status — whether other courts must follow this ruling
- Published
- Procedural Posture — the stage the case had reached
- appeal
- Circuit
- Federal Circuit
Related Laws
No specific laws identified for this ruling.
Outcome
The Federal Circuit affirmed the lower court's decision, denying Athena's petition for rehearing en banc. The patent claims were found ineligible under 35 U.S.C. § 101 as directed to a natural law (the correlation between MuSK autoantibodies and myasthenia gravis) combined with conventional detection steps.
What This Ruling Means
This summary was generated to explain the ruling in plain English and is not legal advice.
Similar Rulings
Browse Related
Facing something similar at work?
Court rulings like this one are useful, but every situation is different. Take 2 minutes to see which laws may protect you — it's free, private, and no account is required to start.
This ruling information is sourced from public court records via CourtListener.com. Case outcomes, claim types, and summaries are extracted using AI analysis and may be incomplete or inaccurate. It is provided for informational and educational purposes only and does not constitute legal advice.
See something wrong, or named in this ruling and want it corrected or redacted? Request a correction.